(CSUS) iShares VII - iShares MSCI - Ratings and Ratios
Exchange: AS • Country: Netherlands • Currency: EUR • Type: Etf • ISIN: IE00B52SFT06 • US Large-Cap Blend Equity
CSUS: Stocks, Bonds, US, Equities
The iShares VII PLC - iShares MSCI USA ETF USD Acc (AS:CSUS) is a Netherlands-domiciled ETF designed to track the performance of large- and mid-cap US equities. It provides exposure to a broad range of US companies, aligning with the Morningstar US Large-Mid NR USD Index. The fund is managed by BlackRock, a leading global asset manager, and is listed on the Euronext Amsterdam exchange under the ticker symbol CSUS.
From a technical perspective, CSUS has shown a recent price of 557.95, below its short-term moving averages (SMA 20: 592.07, SMA 50: 591.07). The SMA 200 stands at 545.94, indicating a potential long-term support level. The Average True Range (ATR) of 6.37 reflects moderate volatility, while the 20-day average volume of 1,066 suggests limited trading activity compared to larger ETFs.
Fundamentally, the ETF holds approximately 1,954.46 million EUR in assets under management (AUM), making it a substantial fund in its category. Its focus on US large-cap equities positions it as a core holding for investors seeking exposure to the US market.
3-Month Forecast: Based on the current technical and fundamental data, CSUS is expected to face headwinds in the short term due to its position below key moving averages. However, the relatively low ATR suggests volatility may remain contained. The funds long-term outlook remains tied to the performance of the US large-cap equity market, which is expected to stabilize as interest rate volatility subsides. Investors should monitor the funds ability to reclaim its SMA 50 level as a potential sign of strength.
Additional Sources for CSUS ETF
CSUS ETF Overview
Market Cap in USD | 2,432m |
Category | US Large-Cap Blend Equity |
TER | 0.07% |
IPO / Inception | 2010-01-12 |
CSUS ETF Ratings
Growth 5y | 76.4% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength | -3.23 |
Analysts | - |
Fair Price Momentum | 422.43 EUR |
Fair Price DCF | - |
CSUS Dividends
No Dividends PaidCSUS Growth Ratios
Growth Correlation 3m | -73% |
Growth Correlation 12m | 77.8% |
Growth Correlation 5y | 90.6% |
CAGR 5y | 13.15% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | 0.94 |
Alpha | -2.60 |
Beta | 0.937 |
Volatility | 20.67% |
Current Volume | 1.9k |
Average Volume 20d | 1.7k |
As of April 09, 2025, the stock is trading at EUR 463.56 with a total of 1,856 shares traded.
Over the past week, the price has changed by -11.69%, over one month by -13.54%, over three months by -21.15% and over the past year by -4.71%.
Yes. Based on ValueRay Analyses, iShares VII - iShares MSCI (AS:CSUS) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 76.41 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CSUS as of April 2025 is 422.43. This means that CSUS is currently overvalued and has a potential downside of -8.87%.
iShares VII - iShares MSCI has no consensus analysts rating.
According to ValueRays Forecast Model, CSUS iShares VII - iShares MSCI will be worth about 468.7 in April 2026. The stock is currently trading at 463.56. This means that the stock has a potential upside of +1.12%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 468.7 | 1.1% |